Dr. Oberley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4610 S 44th Pl
Phoenix, AZ 85040
Summary
- Dr. Matthew Oberley is Executive Medical Director at Caris Life Sciences. He is also a pathologist in Hollywood, CA and is affiliated with Children's Hospital Los Angeles. He received his medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 8 years. He specializes in hematopathology and is experienced in hematopathology, surgical pathology, molecular pathology, and MRD evaluation by flow cytometry.
Education & Training
- University of Wisconsin School of Medicine & Public Health2013 - 2014
- University of Wisconsin Hospitals and ClinicsResidency, Pathology-Anatomic and Clinical, 2009 - 2013
- University of Wisconsin School of Medicine & Public HealthClass of 2009
- McArdle Laboratory for Cancer Research, University of Wisconsin School of Medicine and Public HealthPhD, Oncology, 2000 - 2003
- University of Wisconsin FoundationPh.D., Molecular Toxicology, 2003
- University of Colorado BoulderBA, Environmental, Population, and Organismic Biology, 1991 - 1995
- University of Colorado BoulderB.A., Biology, 1995
Certifications & Licensure
- AZ State Medical License 2020 - 2027
- CA State Medical License 2015 - 2026
- TX State Medical License 2020 - 2025
- WI State Medical License 2011 - 2025
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Hematology
Awards, Honors, & Recognition
- Young Investigator Mentee Children's Oncology Group, 2016
- Resident/Fellow Presentation Award Michael N. Hart Research Day, 2013
- Ruth L. Kirschstein National Research Service Award National Cancer Institute postdoctoral fellowship, 2003, 2004
- Join now to see all
Publications & Presentations
PubMed
- Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma.Michael D Toboni, Kaitlyn Dinkins, Sharon Wu, Tyler Mattox, Matthew J Oberley
Gynecologic Oncology. 2025-01-20 - Loss of O6-Methylguanine-DNA Methyltransferase Protein Expression by Immunohistochemistry Is Associated With Response to Capecitabine and Temozolomide in Neuroendocrin...Mark G Evans, Joanne Xiu, Sourat Darabi, Anthony Crymes, Adam Bedeir
World Journal of Surgery. 2025-01-17 - Comprehensive analysis of targetable mutations and tumor microenvironment in urachal cancer.David J Benjamin, Tolulope T Adeyelu, Andrew Elliott, Sourat Darabi, Thomas Lee
NPJ Precision Oncology. 2025-01-11
Journal Articles
- Congenital B-lymphoblastic leukemia with a cryptic MLL rearrangement and post-treatment evolution to mixed phenotype acute leukemiaMoschiano E, Raca G, Fu C, Pattengale PK, Oberley MJ, Leuk Res Rep, 1/1/2016
- Lymphoproliferative disorder with Auer rod-like inclusionsOberley MJ, Yang DT, Blood, 1/1/2014
- Vav1 in hematologic neoplasms, a mini reviewOberley MJ, Wang D, and Yang D, American Journal of Blood Research, 1/1/2012
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Predictive Value of Minimal Residual Disease in WHO2016Defined Mixed Phenotype Acute Leukemia (MPAL).Orgel E, Oberley MJ, Li S, Malvar J, and O'Gorman MRG, ASH 58th Annual Meeting, San Diego, CA, 1/1/2016
- Identification of Novel and Recurrent Copy Number Alterations in Pediatric High Grade B-cell Lymphoma by Chromosomal Microarray.Hagiya A, Raca G, and Oberley MJ, USC Depatment of Pathology Research Retreat, Long Beach, CA, 1/1/2016
- A comprehensive gene panel for precise diagnosis and treatment of childhood cancer.Triche TJ, Biegel J, Judkins A, Busse T, Wayne A, Bhojwani D, Asgharzadeh S, Oberley MJ, Parham D, AACR, New Orleans, LA, 1/1/2016
- Join now to see all
Lectures
- Large B-Cell Lymphomas in Pediatric and Young Adults Display Clinically Relevant Molecular Features Distinguishable from Adult Counterparts2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Predictive Value of Minimal Residual Disease in WHO2016-Defined Mixed Phenotype Acute LeukemiaUniversity of Wisconsin-Madison - 1/23/2017
- Clinical Significance of Isolated Myeloperoxidase Expression in B Lymphoblastic Leukemia.Atlanta, GA - 1/16/2016
- Join now to see all
Press Mentions
- Study: Low-Calorie Diet, Exercise Improve Survival for Children with LeukemiaApril 1st, 2021
- Kids with Cancer Could Be Helped with Low-Calorie Diet, ExerciseApril 1st, 2021
- Caris Life Sciences Appoints New Executive Medical DirectorFebruary 11th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: